These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7537491)

  • 21. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.
    Giessauf A; Letschka T; Walder G; Dierich MP; Würzner R
    J Immunol Methods; 2004 Apr; 287(1-2):1-11. PubMed ID: 15099751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chaperone-aided in vitro renaturation of an engineered E1 envelope protein for detection of anti-Rubella virus IgG antibodies.
    Scholz C; Thirault L; Schaarschmidt P; Zarnt T; Faatz E; Engel AM; Upmeier B; Bollhagen R; Eckert B; Schmid FX
    Biochemistry; 2008 Apr; 47(14):4276-87. PubMed ID: 18330994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different affinity of monoclonal antibodies for conserved neutralizing epitopes on two strains of rubella virus.
    Cordoba P; Grutadauria S; Cuffini C; Zapata MT
    Viral Immunol; 1997; 10(2):103-10. PubMed ID: 9210284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both Sphingomyelin and Cholesterol in the Host Cell Membrane Are Essential for Rubella Virus Entry.
    Otsuki N; Sakata M; Saito K; Okamoto K; Mori Y; Hanada K; Takeda M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoaffinity purification of baculovirus-expressed rubella virus E1 for diagnostic purposes.
    Lindqvist C; Schmidt M; Heinola J; Jaatinen R; Osterblad M; Salmi A; Keränen S; Akerman K; Oker-Blom C
    J Clin Microbiol; 1994 Sep; 32(9):2192-6. PubMed ID: 7814545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Genetic characterization of rubella virus isolated in Guizhou Province from 2012 to 2015].
    Tang XM; Zhu Z; Ren G; Ye XF; Zhang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Dec; 51(12):1108-1112. PubMed ID: 29262493
    [No Abstract]   [Full Text] [Related]  

  • 28. R237 and h238 are key amino acids in the rubella virus E1 neutralization epitope.
    Li ZM; Chu FL; Wen HL; Sun ZH; Li GH; Xie WY; Wang ZY
    Viral Immunol; 2014 Nov; 27(9):422-9. PubMed ID: 25226223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of contiguous allele-specific peptide elements in the rubella virus E1 envelope protein.
    Nepom GT; Domeier ME; Ou D; Kovats S; Mitchell LA; Tingle AJ
    Vaccine; 1997; 15(6-7):648-52. PubMed ID: 9178465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of rubella virus strain differences associated with attenuation.
    Chantler JK; Lund KD; Miki NP; Berkowitz CA; Tai G
    Intervirology; 1993; 36(4):225-36. PubMed ID: 8169114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
    Wen H; Wang Z
    Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.
    Brown LE; Murray JM; White DO; Jackson DC
    Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.
    Li L; Barrett AD; Beasley DW
    Virology; 2005 Apr; 335(1):99-105. PubMed ID: 15823609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and evolutionary insight from the crystal structure of rubella virus protein E1.
    DuBois RM; Vaney MC; Tortorici MA; Kurdi RA; Barba-Spaeth G; Krey T; Rey FA
    Nature; 2013 Jan; 493(7433):552-6. PubMed ID: 23292515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic characterization analysis on epidemic rubella virus strains isolated in Liaoning from 2007 to 2012].
    Wang Y; Ma Y; Xu XT; Fan XS; Lin Q; Sui D; Yin Y; Wu FT; Pan BL; Liu GY; Wang JJ; Han Y; Guo JQ; Zhao Z
    Bing Du Xue Bao; 2013 Nov; 29(6):589-95. PubMed ID: 24520763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis.
    Chanas AC; Gould EA; Clegg JC; Varma MG
    J Gen Virol; 1982 Jan; 58 Pt 1():37-46. PubMed ID: 7142968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-Dependent Rubella Virus Fusion Occurs in Early Endosomes.
    Dubé M; Etienne L; Fels M; Kielian M
    J Virol; 2016 Jul; 90(14):6303-6313. PubMed ID: 27122589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes.
    Hevey M; Negley D; Schmaljohn A
    Virology; 2003 Sep; 314(1):350-7. PubMed ID: 14517087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
    van Rijn PA; van Gennip HG; de Meijer EJ; Moormann RJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2053-60. PubMed ID: 7691986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of rubella virus E1 glycosylation mutants expressed in COS cells.
    Hobman TC; Qiu ZY; Chaye H; Gillam S
    Virology; 1991 Apr; 181(2):768-72. PubMed ID: 2014650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.